We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting. For more information about the use of cookies or our use of data, see our Cookies notice or Privacy notice

Cookies settings I agree I refuse

Cookies information

Our site uses tools, such as cookies, to analyze and improve your experience. You can unsubscribe below:

Statistics

We use tools, such as Google Analytics, to track web traffic and verify the effectiveness of our site.

Necessary

Cookies required for essential services and features such as login forms, shopping cart integration and access control. Without them, our website cannot function properly and we cannot provide any services. Deactivation is not available.

These settings will be kept for 24h

Publications

Are Ticks the Answer to Medical Device-Associated Clotting?

Are Ticks the Answer to Medical Device-Associated Clotting?
Check the link
Publications
Are Ticks the Answer to Medical Device-Associated Clotting?

Editorial Comment

Jeffrey I. WeitzA, Noel C. ChanA

  • A
    McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada

Documents

Publication

Introduction

Medical devices such as coronary catheters and mechanical heart valves (MHVs) and extracorporeal cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) circuits activate factor XII (FXII) and trigger clotting via the intrinsic pathway of coagulation (1). Heparin prevents catheter thrombosis during percutaneous coronary intervention and clotting of CPB and ECMO circuits, whereas warfarin suppresses clotting with MHVs. Although effective, heparin and warfarin require coagulation monitoring and dose adjustments, which is inconvenient, and protamine sulfate used to reverse heparin after CPB surgery can cause potentially fatal allergic reactions. Furthermore, the high doses of heparin used to prevent clotting of extracorporeal circuits can cause bleeding, as can warfarin. Therefore, safer and more convenient anticoagulant agents are needed to prevent clotting on medical devices.